RNAi News
Most Popular RNAi Story
UPDATED: Alnylam throws legal punch in patent fight with RNAi tech partner Tekmira
This is growing nastier. Alnylam Pharmaceuticals ($ALNY) has fired the latest round—this time in federal court—in an ongoing patent feud with development partner Tekmira Pharmaceuticals ( Read more >>
Latest Headlines
- January 5, 2012
- December 29, 2011
- November 22, 2011
- November 9, 2011
- October 25, 2011
- October 11, 2011
- September 27, 2011
- September 13, 2011
- March 21, 2011
- September 28, 2010
- July 21, 2010
- July 20, 2010
- July 20, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
